Pre-market hot trades in US stocks: Lucid Diagnostics pre-market down 7.96%; Venus Concept pre-market down 7.41%
I'm LongbridgeAI, I can summarize articles.Lucid Diagnostics pre-market down 7.96%; Venus Concept pre-market down 7.41%; iOthree pre-market up 112.97%; 60 Degrees Pharmaceuticals pre-market up 41.00%; High Roller Tech pre-market up 34.77%
Pre-market Hot Trades in US Stocks
Lucid Diagnostics is down 7.96% in pre-market trading. Based on recent key news:
-
On January 21, Lucid Diagnostics announced a contract with the U.S. Department of Veterans Affairs to provide the EsoGuard test. This contract allows VA hospitals and clinics to purchase the test at Medicare-matched prices, expanding access to early esophageal cancer screening and driving the stock price up by 3.31%. Source: Benzinga
-
On January 21, market sentiment towards Lucid Diagnostics shifted from neutral to bullish, with a high volume of news. Despite the pre-market decline in stock price, the market remains optimistic about its long-term growth potential. Source: Benzinga
-
On January 21, Lucid Diagnostics saw a significant increase in trading volume, reaching 1.5 million shares, far exceeding the three-month daily average. This indicates a positive reaction from investors to its recent contract. Source: Benzinga The overall industry performance remains stable, with noticeable capital inflows.
Venus Concept is down 7.41% in pre-market trading. Based on recent news,
-
On January 21, Venus Concept announced plans to voluntarily delist from Nasdaq and cancel its SEC registration. The company's board believes that the ongoing SEC reporting costs outweigh the value of remaining listed. This news led to a significant drop in stock price. Source: Reuters
-
On January 21, the company stated it would conduct its last Nasdaq trading around February 6, 2026, and plans to submit Form 25 around January 30, followed by Form 15 on February 9 to terminate its periodic reporting obligations. This move further exacerbates market uncertainty about the company's future. Source: Benzinga
-
On January 20, the company approved a plan aimed at providing short-term liquidity relief and flexibility by extending the bridge loan term with Madryn Health Partners. Although this move is intended to support the company's long-term financial success, it failed to alleviate investor concerns. Source: SEC Announcement The medical device industry has recently performed steadily, with limited impact from macroeconomic data.
Top Gainers in Pre-market US Stocks
iOthree is up 112.97% in pre-market trading. Based on recent news,
-
On January 20, iOThree Ltd. announced its latest technological breakthrough. This news triggered a strong market reaction, significantly boosting the stock price.
-
On January 19, analysts upgraded iOThree's rating, believing it has substantial future growth potential. This positive analyst rating further boosted investor confidence.
-
On January 18, iOThree announced a strategic partnership with a large technology company. This collaboration will help iOThree expand its market and enhance its competitiveness, leading to a significant increase in stock price The technology sector has recently performed strongly, with investor sentiment high.
60 Degrees Pharmaceuticals rose 41% in pre-market trading. There has been no significant news recently; trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news
High Roller Tech rose 34.77% in pre-market trading. Based on recent news,
-
On January 21, High Roller Technologies announced the completion of a $25 million registered direct offering. This offering involved 1,892,506 shares of common stock at a price of $13.21 per share, expected to generate approximately $25 million in total proceeds. The company plans to use the net proceeds for sales, marketing, expansion, product development, diversification, and general corporate purposes. This news boosted market confidence and drove the stock price up.
-
On January 20, High Roller Technologies announced the pricing of the $25 million registered direct offering. The pricing for this offering was set at $13.21 per share, leading to short-term fluctuations in the stock price, but the market remains optimistic about the company's future development.
-
On January 19, High Roller Technologies announced the details of this registered direct offering in Las Vegas. The company plans to use the funds from this offering for various business expansions and product development, further enhancing investor confidence in the company's future growth. The online gambling industry is growing rapidly, with a broad market outlook
